医学临床研究
醫學臨床研究
의학림상연구
JOURNAL OF CLINICAL RESEARCH
2014年
12期
2374-2376
,共3页
刘峰%雷青%陈立%陈松%阳宏奇%倪江东
劉峰%雷青%陳立%陳鬆%暘宏奇%倪江東
류봉%뢰청%진립%진송%양굉기%예강동
关节成形术,置换,髋/副作用%吗啉类/治疗应用%血栓形成/预防和控制
關節成形術,置換,髖/副作用%嗎啉類/治療應用%血栓形成/預防和控製
관절성형술,치환,관/부작용%마람류/치료응용%혈전형성/예방화공제
Arthroplasty,Replacement,Hip/AE%Morpholines/TUThrombosis/PC
目的比较利伐沙班与依诺肝素预防股骨颈骨折人工全髋关节置换术后下肢深静脉血栓形成(DVT)的有效性及安全性。方法选取本院2012年7月至2013年7月收治的105例股骨颈骨折行人工全髋关节置换术的老年患者为研究对象,经患者及家属知情同意用药方案,将以上患者分为利伐沙班组和依诺肝素组。通过观察两组患者术后静脉血栓栓塞症(VTE)的相关临床症状及体征,行血管彩超及 CTA检查诊断统计 DVT和肺栓塞(PE)例数,评价其有效性。统计两组患者出血事件、额外输血率评价其安全性。结果两组患者均没有出现PE,均无出现大出血事件。而DVT的发生率,一般出血事件发生率,额外输血率,两组比较差异均无统计学意义(P>0.05)。结论利伐沙班对比依诺肝素,对老年股骨颈骨折患者行人工全髋关节置换术后预防 VTE 发生具有同样良好的效果,并且未增加出血风险。
目的比較利伐沙班與依諾肝素預防股骨頸骨摺人工全髖關節置換術後下肢深靜脈血栓形成(DVT)的有效性及安全性。方法選取本院2012年7月至2013年7月收治的105例股骨頸骨摺行人工全髖關節置換術的老年患者為研究對象,經患者及傢屬知情同意用藥方案,將以上患者分為利伐沙班組和依諾肝素組。通過觀察兩組患者術後靜脈血栓栓塞癥(VTE)的相關臨床癥狀及體徵,行血管綵超及 CTA檢查診斷統計 DVT和肺栓塞(PE)例數,評價其有效性。統計兩組患者齣血事件、額外輸血率評價其安全性。結果兩組患者均沒有齣現PE,均無齣現大齣血事件。而DVT的髮生率,一般齣血事件髮生率,額外輸血率,兩組比較差異均無統計學意義(P>0.05)。結論利伐沙班對比依諾肝素,對老年股骨頸骨摺患者行人工全髖關節置換術後預防 VTE 髮生具有同樣良好的效果,併且未增加齣血風險。
목적비교리벌사반여의낙간소예방고골경골절인공전관관절치환술후하지심정맥혈전형성(DVT)적유효성급안전성。방법선취본원2012년7월지2013년7월수치적105례고골경골절행인공전관관절치환술적노년환자위연구대상,경환자급가속지정동의용약방안,장이상환자분위리벌사반조화의낙간소조。통과관찰량조환자술후정맥혈전전새증(VTE)적상관림상증상급체정,행혈관채초급 CTA검사진단통계 DVT화폐전새(PE)례수,평개기유효성。통계량조환자출혈사건、액외수혈솔평개기안전성。결과량조환자균몰유출현PE,균무출현대출혈사건。이DVT적발생솔,일반출혈사건발생솔,액외수혈솔,량조비교차이균무통계학의의(P>0.05)。결론리벌사반대비의낙간소,대노년고골경골절환자행인공전관관절치환술후예방 VTE 발생구유동양량호적효과,병차미증가출혈풍험。
Obj ective]To compare the effectiveness and safety of rivaroxaban vs.enoxaparin in the prophylax-is of deep venous thromboembolism(DVT)of lower limbs in femoral neck fracture after total hip replacement.[Methods]Totally 105 elderly patients with femoral neck fracture undergoing total hip replacement in our hospital from July 2012 to July 2013 were enrolled in the study.After the informed consent of patients and their families to the treatment schedule,above patients were divided into rivaroxaban group and enoxaparin group.Clinical symp-toms and signs related to VTE of patients in 2 groups after operation were observed.Vascular color Doppler ultra-sonography and CT angiography(CTA)were performed to calculate the number of DVT and pulmonary embolism (PE).The effectiveness was assessed.The bleeding events and additional transfusion rate were calculated to as-sess the safety.[Results]No PE and large hemorrhage event were found in two groups.There was no significant difference in the incidence of DVT and common bleeding events and additional transfusion rate between two groups (P>0.05).[Conclusion]Rivaroxaban for preventing DVT in elderly patients with femoral neck fracture after to-tal hip replacement has the same efficacy as enoxaparin without increasing bleeding risk.